effect than ect Search Results


effect than ect  (MedChemExpress)
93
MedChemExpress effect than ect
Network geometry for the comparisons of <t>A</t> <t>Shoulder</t> Disability Index and B Shoulder Pain Score. TT, traditional training; <t>ECT,</t> eccentric strengthening training; CST, concentric strengthening training; SFT, scapula-focused training; MCE, motor control exercise; LLT, low-load training. The size of each node corresponds to the number of participants in that intervention arm. The width of the connecting lines represents the number of direct comparisons between intervention arms
Effect Than Ect, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/effect than ect/product/MedChemExpress
Average 93 stars, based on 1 article reviews
effect than ect - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
unilateral ect  (Institute for Clinical Pharmacodynamics)
90
Institute for Clinical Pharmacodynamics unilateral ect
Network geometry for the comparisons of <t>A</t> <t>Shoulder</t> Disability Index and B Shoulder Pain Score. TT, traditional training; <t>ECT,</t> eccentric strengthening training; CST, concentric strengthening training; SFT, scapula-focused training; MCE, motor control exercise; LLT, low-load training. The size of each node corresponds to the number of participants in that intervention arm. The width of the connecting lines represents the number of direct comparisons between intervention arms
Unilateral Ect, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/unilateral ect/product/Institute for Clinical Pharmacodynamics
Average 90 stars, based on 1 article reviews
unilateral ect - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
poc-ecarin clotting time (poc-ect  (Helena Laboratories)
90
Helena Laboratories poc-ecarin clotting time (poc-ect
Diagnostic accuracy of point-of-care <t>ecarin</t> <t>clotting</t> <t>time</t> <t>(POC-ECT),</t> laboratory-based ECT, and laboratory-based Biophen Direct Thrombin Inhibitor (BDTI) assay. Scatter plots illustrate the correlation between dabigatran plasma concentrations determined by ultra-performance liquid chromatography/tandem mass spectrometry and ( A ) POC-ECT with whole blood (WB), ( B ) citrated blood (CB), ( C ) citrated plasma (CP) as well as ( D ) calibrated laboratory-based (lab.) ECT, and ( E ) calibrated laboratory-based (lab) BDTI. Green shaded bars indicate the treatment-relevant dabigatran plasma concentration thresholds of 30 ( darker ) and 50 ng/mL ( lighter ). Horizontal gray lines indicate suggested optimal cut-offs providing >95% sensitivity for detection of samples containing >30 ( solid ) and >50 ng/mL ( dashed ) of dabigatran. Diagonal black lines indicate regression lines with their respective equations and the squared Pearson's correlation coefficient ( R 2 ) to be found in the upper left corner of the diagrams.
Poc Ecarin Clotting Time (Poc Ect, supplied by Helena Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poc-ecarin clotting time (poc-ect/product/Helena Laboratories
Average 90 stars, based on 1 article reviews
poc-ecarin clotting time (poc-ect - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
hippocampal volume increase  (Abbott Laboratories)
90
Abbott Laboratories hippocampal volume increase
Diagnostic accuracy of point-of-care <t>ecarin</t> <t>clotting</t> <t>time</t> <t>(POC-ECT),</t> laboratory-based ECT, and laboratory-based Biophen Direct Thrombin Inhibitor (BDTI) assay. Scatter plots illustrate the correlation between dabigatran plasma concentrations determined by ultra-performance liquid chromatography/tandem mass spectrometry and ( A ) POC-ECT with whole blood (WB), ( B ) citrated blood (CB), ( C ) citrated plasma (CP) as well as ( D ) calibrated laboratory-based (lab.) ECT, and ( E ) calibrated laboratory-based (lab) BDTI. Green shaded bars indicate the treatment-relevant dabigatran plasma concentration thresholds of 30 ( darker ) and 50 ng/mL ( lighter ). Horizontal gray lines indicate suggested optimal cut-offs providing >95% sensitivity for detection of samples containing >30 ( solid ) and >50 ng/mL ( dashed ) of dabigatran. Diagonal black lines indicate regression lines with their respective equations and the squared Pearson's correlation coefficient ( R 2 ) to be found in the upper left corner of the diagrams.
Hippocampal Volume Increase, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hippocampal volume increase/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
hippocampal volume increase - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
recombinant pseudomonas syringae pv tomato effector protein hopm1  (Cusabio)
N/A
   Buy from Supplier
death effector domain containing human recombinant  (RayBiotech)
N/A
Death Effector Domain Containing Human Recombinant 10 ug
   Buy from Supplier
recombinant human death effector domain containing protein  (Cusabio)
N/A
   Buy from Supplier
titanium oxide nanopowder  (Chem Impex International)
N/A
   Buy from Supplier
recombinant mouse wd repeat containing and planar cell polarity effector protein fritz homolog  (Cusabio)
N/A
   Buy from Supplier
cell death inducing dffa like effector c human recombinant  (RayBiotech)
N/A
Cell Death Inducing DFFA Like Effector C Human Recombinant 10 ug
   Buy from Supplier
titanium oxide nanopowder , anatase and rutile mixture  (Chem Impex International)
N/A
   Buy from Supplier
recombinant human p53 apoptosis effector related to pmp 22  (Cusabio)
N/A
   Buy from Supplier

Image Search Results


Network geometry for the comparisons of A Shoulder Disability Index and B Shoulder Pain Score. TT, traditional training; ECT, eccentric strengthening training; CST, concentric strengthening training; SFT, scapula-focused training; MCE, motor control exercise; LLT, low-load training. The size of each node corresponds to the number of participants in that intervention arm. The width of the connecting lines represents the number of direct comparisons between intervention arms

Journal: Journal of Orthopaedic Surgery and Research

Article Title: Effects of seven types of exercise in the treatment of rotator cuff-related shoulder pain (RCRSP): a systematic review and Bayesian network meta-analysis

doi: 10.1186/s13018-025-06514-4

Figure Lengend Snippet: Network geometry for the comparisons of A Shoulder Disability Index and B Shoulder Pain Score. TT, traditional training; ECT, eccentric strengthening training; CST, concentric strengthening training; SFT, scapula-focused training; MCE, motor control exercise; LLT, low-load training. The size of each node corresponds to the number of participants in that intervention arm. The width of the connecting lines represents the number of direct comparisons between intervention arms

Article Snippet: For the Shoulder Disability Index, CST showed a significantly greater effect than ECT (SMD = 3.49; 95%CrI [0.28, 6.7]), HLT (SMD = 23.87; 95%CrI [4.81, 42.92]), LLT (SMD = 22.90; 95%CrI [3.72, 42.1]), MCE (SMD = 12.04; 95%CrI [5.21, 18.88]), SFT (SMD = 12.65; 95%CrI [5.83, 19.4]), and TT (SMD = 5.91; 95%CrI [0.64, 11.17]), and the relative effect of ECT was greater than HLT (SMD = 20.38; 95%CrI [1.6, 39.14]), LLT (SMD = 19.40; 95%CrI [0.49, 38.35]), MCE (SMD = 8.55; 95%CrI [2.52, 14.55]) and SFT (SMD = 9.16; 95%CrI [3.19, 15.11]).

Techniques: Control

Surface Under the Cumulative Ranking Curve (SUCRA) for Exercise Interventions. A Shoulder disability index. B Shoulder pain score. Higher SUCRA values indicate a higher probability of being the most effective intervention. CST, Concentric Strengthening Training; ECT, Eccentric Strengthening Training; HLT, High-Load Training; LLT, Low-Load Training; MCE, Motor Control Exercise; SFT, Scapula-Focused Training; TT, Traditional Training

Journal: Journal of Orthopaedic Surgery and Research

Article Title: Effects of seven types of exercise in the treatment of rotator cuff-related shoulder pain (RCRSP): a systematic review and Bayesian network meta-analysis

doi: 10.1186/s13018-025-06514-4

Figure Lengend Snippet: Surface Under the Cumulative Ranking Curve (SUCRA) for Exercise Interventions. A Shoulder disability index. B Shoulder pain score. Higher SUCRA values indicate a higher probability of being the most effective intervention. CST, Concentric Strengthening Training; ECT, Eccentric Strengthening Training; HLT, High-Load Training; LLT, Low-Load Training; MCE, Motor Control Exercise; SFT, Scapula-Focused Training; TT, Traditional Training

Article Snippet: For the Shoulder Disability Index, CST showed a significantly greater effect than ECT (SMD = 3.49; 95%CrI [0.28, 6.7]), HLT (SMD = 23.87; 95%CrI [4.81, 42.92]), LLT (SMD = 22.90; 95%CrI [3.72, 42.1]), MCE (SMD = 12.04; 95%CrI [5.21, 18.88]), SFT (SMD = 12.65; 95%CrI [5.83, 19.4]), and TT (SMD = 5.91; 95%CrI [0.64, 11.17]), and the relative effect of ECT was greater than HLT (SMD = 20.38; 95%CrI [1.6, 39.14]), LLT (SMD = 19.40; 95%CrI [0.49, 38.35]), MCE (SMD = 8.55; 95%CrI [2.52, 14.55]) and SFT (SMD = 9.16; 95%CrI [3.19, 15.11]).

Techniques: Control

Funnel plots assessing potential publication bias for each outcome. A Shoulder Disability Index. B Shoulder Pain Score. Symmetrical distribution of the plotted comparisons suggests a low risk of publication bias. CST, Concentric Strengthening Training; ECT, Eccentric Strengthening Training; HLT, High-Load Training; LLT, Low-Load Training; MCE, Motor Control Exercise; SFT, Scapula-Focused Training; TT, Traditional Training

Journal: Journal of Orthopaedic Surgery and Research

Article Title: Effects of seven types of exercise in the treatment of rotator cuff-related shoulder pain (RCRSP): a systematic review and Bayesian network meta-analysis

doi: 10.1186/s13018-025-06514-4

Figure Lengend Snippet: Funnel plots assessing potential publication bias for each outcome. A Shoulder Disability Index. B Shoulder Pain Score. Symmetrical distribution of the plotted comparisons suggests a low risk of publication bias. CST, Concentric Strengthening Training; ECT, Eccentric Strengthening Training; HLT, High-Load Training; LLT, Low-Load Training; MCE, Motor Control Exercise; SFT, Scapula-Focused Training; TT, Traditional Training

Article Snippet: For the Shoulder Disability Index, CST showed a significantly greater effect than ECT (SMD = 3.49; 95%CrI [0.28, 6.7]), HLT (SMD = 23.87; 95%CrI [4.81, 42.92]), LLT (SMD = 22.90; 95%CrI [3.72, 42.1]), MCE (SMD = 12.04; 95%CrI [5.21, 18.88]), SFT (SMD = 12.65; 95%CrI [5.83, 19.4]), and TT (SMD = 5.91; 95%CrI [0.64, 11.17]), and the relative effect of ECT was greater than HLT (SMD = 20.38; 95%CrI [1.6, 39.14]), LLT (SMD = 19.40; 95%CrI [0.49, 38.35]), MCE (SMD = 8.55; 95%CrI [2.52, 14.55]) and SFT (SMD = 9.16; 95%CrI [3.19, 15.11]).

Techniques: Control

Diagnostic accuracy of point-of-care ecarin clotting time (POC-ECT), laboratory-based ECT, and laboratory-based Biophen Direct Thrombin Inhibitor (BDTI) assay. Scatter plots illustrate the correlation between dabigatran plasma concentrations determined by ultra-performance liquid chromatography/tandem mass spectrometry and ( A ) POC-ECT with whole blood (WB), ( B ) citrated blood (CB), ( C ) citrated plasma (CP) as well as ( D ) calibrated laboratory-based (lab.) ECT, and ( E ) calibrated laboratory-based (lab) BDTI. Green shaded bars indicate the treatment-relevant dabigatran plasma concentration thresholds of 30 ( darker ) and 50 ng/mL ( lighter ). Horizontal gray lines indicate suggested optimal cut-offs providing >95% sensitivity for detection of samples containing >30 ( solid ) and >50 ng/mL ( dashed ) of dabigatran. Diagonal black lines indicate regression lines with their respective equations and the squared Pearson's correlation coefficient ( R 2 ) to be found in the upper left corner of the diagrams.

Journal: Thrombosis and Haemostasis

Article Title: Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran

doi: 10.1055/s-0040-1721775

Figure Lengend Snippet: Diagnostic accuracy of point-of-care ecarin clotting time (POC-ECT), laboratory-based ECT, and laboratory-based Biophen Direct Thrombin Inhibitor (BDTI) assay. Scatter plots illustrate the correlation between dabigatran plasma concentrations determined by ultra-performance liquid chromatography/tandem mass spectrometry and ( A ) POC-ECT with whole blood (WB), ( B ) citrated blood (CB), ( C ) citrated plasma (CP) as well as ( D ) calibrated laboratory-based (lab.) ECT, and ( E ) calibrated laboratory-based (lab) BDTI. Green shaded bars indicate the treatment-relevant dabigatran plasma concentration thresholds of 30 ( darker ) and 50 ng/mL ( lighter ). Horizontal gray lines indicate suggested optimal cut-offs providing >95% sensitivity for detection of samples containing >30 ( solid ) and >50 ng/mL ( dashed ) of dabigatran. Diagonal black lines indicate regression lines with their respective equations and the squared Pearson's correlation coefficient ( R 2 ) to be found in the upper left corner of the diagrams.

Article Snippet: We aimed to evaluate the direct thrombin monitoring (DTM) test card by Helena Laboratories (Texas, United States) for anti-IIa-specific POC coagulation testing, hypothesizing that its POC-ecarin clotting time (POC-ECT) accurately reflects dabigatran plasma concentrations.

Techniques: Diagnostic Assay, Coagulation, Liquid Chromatography, Mass Spectrometry, Concentration Assay

Sensitivity and specificity regarding detection of dabigatran concentrations >30 and >50 ng/mL

Journal: Thrombosis and Haemostasis

Article Title: Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran

doi: 10.1055/s-0040-1721775

Figure Lengend Snippet: Sensitivity and specificity regarding detection of dabigatran concentrations >30 and >50 ng/mL

Article Snippet: We aimed to evaluate the direct thrombin monitoring (DTM) test card by Helena Laboratories (Texas, United States) for anti-IIa-specific POC coagulation testing, hypothesizing that its POC-ecarin clotting time (POC-ECT) accurately reflects dabigatran plasma concentrations.

Techniques:

Comparison of areas under the ROC curves for detection of dabigatran plasma levels >30 and >50 ng/mL

Journal: Thrombosis and Haemostasis

Article Title: Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran

doi: 10.1055/s-0040-1721775

Figure Lengend Snippet: Comparison of areas under the ROC curves for detection of dabigatran plasma levels >30 and >50 ng/mL

Article Snippet: We aimed to evaluate the direct thrombin monitoring (DTM) test card by Helena Laboratories (Texas, United States) for anti-IIa-specific POC coagulation testing, hypothesizing that its POC-ecarin clotting time (POC-ECT) accurately reflects dabigatran plasma concentrations.

Techniques: Significance Assay

Comparison of agreement with ultra-performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) between calibrated point-of-care ecarin clotting time (POC-ECT) and two calibrated laboratory-based anti-IIa assays. Bland–Altman plots are used to display the agreement level between UPLC-MS/MS and calibrated POC-ECT: ( A ) all data and ( B ) 0–100 ng/mL; calibrated laboratory-based (lab.) ECT: ( C ) all data and ( D ) 0–100 ng/mL; as well as calibrated laboratory-based (lab.) Biophen Direct Thrombin Inhibitor (BDTI) assay: ( E ) all data and ( F ) 0–100 ng/mL; all measurements were performed using citrated plasma. Gray horizontal lines indicate a distance of 1.96 standard deviations ( short-dashed ) from the mean ( long-dashed ). Green shaded bars indicate the dabigatran plasma concentration treatment-relevant thresholds of 30 and 50 ng/mL. Diagonal red lines indicate regression curves with their respective equations and the squared Pearson's correlation coefficient ( R 2 ) to be found in the upper left corner of the diagrams.

Journal: Thrombosis and Haemostasis

Article Title: Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran

doi: 10.1055/s-0040-1721775

Figure Lengend Snippet: Comparison of agreement with ultra-performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) between calibrated point-of-care ecarin clotting time (POC-ECT) and two calibrated laboratory-based anti-IIa assays. Bland–Altman plots are used to display the agreement level between UPLC-MS/MS and calibrated POC-ECT: ( A ) all data and ( B ) 0–100 ng/mL; calibrated laboratory-based (lab.) ECT: ( C ) all data and ( D ) 0–100 ng/mL; as well as calibrated laboratory-based (lab.) Biophen Direct Thrombin Inhibitor (BDTI) assay: ( E ) all data and ( F ) 0–100 ng/mL; all measurements were performed using citrated plasma. Gray horizontal lines indicate a distance of 1.96 standard deviations ( short-dashed ) from the mean ( long-dashed ). Green shaded bars indicate the dabigatran plasma concentration treatment-relevant thresholds of 30 and 50 ng/mL. Diagonal red lines indicate regression curves with their respective equations and the squared Pearson's correlation coefficient ( R 2 ) to be found in the upper left corner of the diagrams.

Article Snippet: We aimed to evaluate the direct thrombin monitoring (DTM) test card by Helena Laboratories (Texas, United States) for anti-IIa-specific POC coagulation testing, hypothesizing that its POC-ecarin clotting time (POC-ECT) accurately reflects dabigatran plasma concentrations.

Techniques: Liquid Chromatography, Mass Spectrometry, Tandem Mass Spectroscopy, Coagulation, Concentration Assay